These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36530994)

  • 21. Genotyping the
    Liang KH; Yang PC; Yeh CT
    Oncol Lett; 2014 Nov; 8(5):2215-2220. PubMed ID: 25295111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression.
    Kim SS; Xu S; Cui J; Poddar S; Le TM; Hayrapetyan H; Li L; Wu N; Moore AM; Zhou L; Yu AC; Dann AM; Elliott IA; Abt ER; Kim W; Dawson DW; Radu CG; Donahue TR
    Theranostics; 2020; 10(2):829-840. PubMed ID: 31903153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphic Variants of
    Bibi K; Fatima T; Sohrab S; Haider G; Zarina S; Ilyas A
    Protein Pept Lett; 2023; 30(7):587-596. PubMed ID: 37254538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
    Lee HL; Cheng HL; Liu YF; Chou MC; Yang SF; Chou YE
    PLoS One; 2017; 12(4):e0176141. PubMed ID: 28426730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis.
    Delage B; Luong P; Maharaj L; O'Riain C; Syed N; Crook T; Hatzimichael E; Papoudou-Bai A; Mitchell TJ; Whittaker SJ; Cerio R; Gribben J; Lemoine N; Bomalaski J; Li CF; Joel S; Fitzgibbon J; Chen LT; Szlosarek PW
    Cell Death Dis; 2012 Jul; 3(7):e342. PubMed ID: 22764101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies.
    Izzo F; Marra P; Beneduce G; Castello G; Vallone P; De Rosa V; Cremona F; Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA; Ng C; Curley SA
    J Clin Oncol; 2004 May; 22(10):1815-22. PubMed ID: 15143074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The
    Chiang CC; Yeh CT; Hwang TL; Chu YD; Lim SN; Chen CW; Kuo CJ; Le PH; Chen TH; Lin WR
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31888240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges.
    Phillips MM; Sheaff MT; Szlosarek PW
    Cancer Res Treat; 2013 Dec; 45(4):251-62. PubMed ID: 24453997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.
    Chu CY; Lee YC; Hsieh CH; Yeh CT; Chao TY; Chen PH; Lin IH; Hsieh TH; Shih JW; Cheng CH; Chang CC; Lin PS; Huang YL; Chen TM; Yen Y; Ann DK; Kung HJ
    Theranostics; 2021; 11(8):3624-3641. PubMed ID: 33664852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment.
    Ye PH; Li CY; Cheng HY; Anuraga G; Wang CY; Chen FW; Yang SJ; Lee KT; Chang KY; Lai MD
    Am J Cancer Res; 2023; 13(5):1952-1969. PubMed ID: 37293150
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Liang KH; Yeh TS; Wu RC; Yeh CN; Yeh CT
    Oncol Lett; 2017 Jun; 13(6):4215-4223. PubMed ID: 28588705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study.
    Yamamoto M; Kobayashi T; Mashima H; Miki D; Kuroda S; Hamaoka M; Aikata H; Chayama K; Ohdan H
    Int J Surg; 2020 Aug; 80():84-90. PubMed ID: 32615319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of CD133 polymorphisms on the risk of developing liver cirrhosis and hepatocellular carcinoma induced by viral hepatitis.
    Hassan M; Nasr SM; Elzallat M
    Virus Res; 2022 Apr; 312():198714. PubMed ID: 35181408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
    Lin WR; Chiang JM; Liang KH; Lim SN; Lai MW; Tsou YK; Hsieh TY; Hsu CK; Yeh CT
    Medicine (Baltimore); 2016 Apr; 95(17):e3487. PubMed ID: 27124048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.
    Thongkum A; Wu C; Li YY; Wangpaichitr M; Navasumrit P; Parnlob V; Sricharunrat T; Bhudhisawasdi V; Ruchirawat M; Savaraj N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.
    Kuo MT; Savaraj N; Feun LG
    Oncotarget; 2010 Aug; 1(4):246-51. PubMed ID: 21152246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
    Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single Nucleotide Polymorphisms in
    Bei C; Liu S; Yu X; Qiu M; Tang B; Liao W; He S; Yu H
    Biomed Res Int; 2018; 2018():1540201. PubMed ID: 30662901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
    Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
    Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.